LifeStance Health Group, Inc.
LFST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -3.84 | 0.20 | -8.21 | -5.37 |
| FCF Yield | 0.80% | 2.85% | -0.40% | 1.99% |
| EV / EBITDA | 114.50 | 207.57 | 188.25 | 207.45 |
| Quality | ||||
| ROIC | 0.09% | -0.10% | -0.04% | 0.04% |
| Gross Margin | 32.04% | 27.34% | 32.97% | 33.62% |
| Cash Conversion Ratio | 25.34 | -16.99 | -4.36 | -8.76 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.84% | 11.14% | 12.19% | 13.33% |
| Free Cash Flow Growth | -69.99% | 652.06% | -118.32% | 216.99% |
| Safety | ||||
| Net Debt / EBITDA | 12.88 | 26.02 | 22.05 | 21.76 |
| Interest Coverage | 2.63 | -1.02 | 0.52 | 0.11 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 25.50 | 30.95 | 34.95 | 33.49 |